The pharmaceutical industry is no stranger to corruption and it should come as no surprise that corporate watchdog Disclosure Insight has warned that Boston Scientific is under investigation by the Securities and Exchange Commission (SEC) for violations of the Foreign Corrupt Practices Act (FCPA). This is not the first time Boston Scientific has been under investigation for foreign […]
